Harrow Health announces board resignation of Kammer and appointment of Sternberg and Makary

HARROW, INC.

Dr. Robert J. Kammer resigned from the board effective March 31, 2022; no disagreements cited.
Board retained Kammer as a special advisor through end of 2022.
Board expanded to six members; appointed Perry J. Sternberg and Dr. Marty Makary as independent directors.
Sternberg is CEO of Corium, Inc.; Makary is chief of islet transplant surgery at Johns Hopkins Hospital.
Sternberg and Makary will receive the Company's standard director compensation package as described in prior proxy.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Perry J. Sternberg

Director

HROW · HARROW, INC.

Effective: 2022-03-31
Filed: March 31, 2022, 7:59 PM ET

the Board appointed Mr. Perry J. Sternberg and Dr. Marty Makary to fill the vacancies created by Dr. Kammer’s resignation and the expansion of the size of the Board.

Departed

Dr. Robert J. Kammer

Director

HROW · HARROW, INC.

Effective: 2022-03-31
Successor: Perry J. Sternberg, Dr. Marty Makary
Filed: March 31, 2022, 7:59 PM ET

On March 31, 2022, Dr. Robert J. Kammer informed the Board of Directors (the “Board”) of Harrow Health, Inc. (the “Company”) that he is resigning as a member of the Company’s Board, with such resignation to be effective immediately.

Appointed

Dr. Marty Makary

Director

HROW · HARROW, INC.

Effective: 2022-03-31
Filed: March 31, 2022, 7:59 PM ET

the Board appointed Mr. Perry J. Sternberg and Dr. Marty Makary to fill the vacancies created by Dr. Kammer’s resignation and the expansion of the size of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Perry J. Sternberg was appointed as Director at HARROW, INC..

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Mr. Perry J. Sternberg and Dr. Marty Makary to fill the vacancies created by Dr. Kammer’s resignation and the expansion of the size of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Robert J. Kammer resigned as Director at HARROW, INC..

Action: resigned
Role: Director

Exact text from the filing

On March 31, 2022, Dr. Robert J. Kammer informed the Board of Directors (the “Board”) of Harrow Health, Inc. (the “Company”) that he is resigning as a member of the Company’s Board, with such resignation to be effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Marty Makary was appointed as Director at HARROW, INC..

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Mr. Perry J. Sternberg and Dr. Marty Makary to fill the vacancies created by Dr. Kammer’s resignation and the expansion of the size of the Board.

View on SEC.gov

HARROW, INC. filing history →

Source: SEC EDGAR

accession 0001493152-22-008268

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.